GoldenGolden
Altitude Life Science Ventures

Altitude Life Science Ventures

A venture capital firm in Colorado that focuses on life science markets with strong demand and growth potential.

All edits by  Cole Hudson 

Edits on 19 Mar, 2020
Cole Hudson
Cole Hudson approved a suggestion from Golden's AI on 19 Mar, 2020
Edits made to:
Article (+17/-17 characters)
Article

Altitude Life Science Ventures is a venture capital firm in Colorado that focuses on life science markets with strong demand and growth potential. Founded 2006 in Durango, Colorado, United States by Steve Johnson and Dave Maki, it invests in early stage ventures and late stage ventures. Its portfolio companies include Omniome, Nuvation Bio, Encoded Therapeutics, Inc., BlackThorn Therapeutics, Vividion Therapeutics, Beam Therapeutics, Millendo Therapeutics, Omniome, UNITY Biotechnology, and Effector Therapeutics. As of March 2020, Altitude Life Science Ventures has made 31 investments. Their most recent investment was on January 9, 2020, when Omniome raised $60M. Altitude Life Science Ventures has had eight exits, the most notable of which include Vir BiotechnologyVir Biotechnology, UNITY Biotechnology, and Receptos. The company has raised a single venture fund, Altitude Life Science Ventures Fund III.

Cole Hudson
Cole Hudson approved a suggestion from Golden's AI on 19 Mar, 2020
Edits made to:
Article (+21/-21 characters)
Article

Altitude Life Science Ventures is a venture capital firm in Colorado that focuses on life science markets with strong demand and growth potential. Founded 2006 in Durango, Colorado, United States by Steve Johnson and Dave Maki, it invests in early stage ventures and late stage ventures. Its portfolio companies include Omniome, Nuvation Bio, Encoded Therapeutics, Inc., BlackThorn Therapeutics, Vividion Therapeutics, Beam Therapeutics, Millendo Therapeutics, Omniome, UNITY Biotechnology, and Effector TherapeuticsEffector Therapeutics. As of March 2020, Altitude Life Science Ventures has made 31 investments. Their most recent investment was on January 9, 2020, when Omniome raised $60M. Altitude Life Science Ventures has had eight exits, the most notable of which include Vir Biotechnology, UNITY Biotechnology, and Receptos. The company has raised a single venture fund, Altitude Life Science Ventures Fund III.

Cole Hudson
Cole Hudson approved a suggestion from Golden's AI on 19 Mar, 2020
Edits made to:
Article (+17/-17 characters)
Article

Altitude Life Science Ventures is a venture capital firm in Colorado that focuses on life science markets with strong demand and growth potential. Founded 2006 in Durango, ColoradoDurango, Colorado, United States by Steve Johnson and Dave Maki, it invests in early stage ventures and late stage ventures. Its portfolio companies include Omniome, Nuvation Bio, Encoded Therapeutics, Inc., BlackThorn Therapeutics, Vividion Therapeutics, Beam Therapeutics, Millendo Therapeutics, Omniome, UNITY Biotechnology, and Effector Therapeutics. As of March 2020, Altitude Life Science Ventures has made 31 investments. Their most recent investment was on January 9, 2020, when Omniome raised $60M. Altitude Life Science Ventures has had eight exits, the most notable of which include Vir Biotechnology, UNITY Biotechnology, and Receptos. The company has raised a single venture fund, Altitude Life Science Ventures Fund III.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.